Page last updated: 2024-10-31

neostigmine and Lathyrism

neostigmine has been researched along with Lathyrism in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Lathyrism: A paralytic condition of the legs caused by ingestion of lathyrogens, especially BETA-AMINOPROPIONITRILE or beta-N-oxalyl amino-L-alanine, which are found in the seeds of plants of the genus LATHYRUS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SINGH, M1
SINGH, G1
CHAUDHURI, RN1
CHHETRI, MK1
SAHA, TK1
MITRA, PP1

Other Studies

2 other studies available for neostigmine and Lathyrism

ArticleYear
Lathyrism: a neurological and economic problem in India.
    The Journal of nervous and mental disease, 1952, Volume: 116, Issue:6

    Topics: Humans; India; Lathyrism; Neostigmine; Vitamins

1952
LATHYRISM: A CLINICAL AND EPIDEMIOLOGICAL STUDY.
    Journal of the Indian Medical Association, 1963, Aug-16, Volume: 41

    Topics: Antigen-Antibody Reactions; Epidemiologic Studies; Epidemiology; Humans; India; Lathyrism; Neostigmi

1963